Navigation Links
Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
Date:12/15/2011

THOUSAND OAKS, Calif., Dec. 15, 2011 /PRNewswire/ -- Kevin W. Sharer, chairman and chief executive officer of Amgen (NASDAQ: AMGN) since 2000, has announced his plan to retire from the Company at the end of 2012, following 20 years of service to Amgen.  To facilitate an orderly transition process, Sharer will step down as CEO effective May 23, 2012, and remain as chairman of the Company's Board of Directors until December 31, 2012, at which time he will retire from the Board and from the Company.  Robert Bradway, currently president and chief operating officer, will become CEO on May 23, 2012.  It is the intention of the Board of Directors to elect Bradway chairman of the Board when Sharer retires from that position at the end of 2012.  The Board will also elect a lead independent director at that time.

On behalf of the Board of Directors, Vance Coffman, chairman of the Board's governance and nominating committee said, "The Board thanks Kevin Sharer for his service in leading Amgen over the past decade.  During that time Amgen grew significantly in every dimension and is well positioned for the future.  Amgen's core mission to serve patients remains our bedrock.  The Board is excited to have a talented executive in Bob Bradway as the fourth CEO in our Company's history."  

"Today Amgen announces its next generation of leaders as we pass the reins to Bob Bradway and Sean Harper," said Kevin Sharer.  "Bob and Sean have demonstrated sound judgment, delivered consistently excellent operating results and provided strong leadership in a variety of challenging roles.  Amgen will be in good hands.  I would particularly like to thank Roger Perlmutter for his eleven years of service.  He has been an outstanding head of research and development, and his accomplishments have benefited millions of patients.  In
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
3. Kevin Garrity Named President of HollisterStier Allergy
4. SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors
5. Amgen Announces Webcast of 2008 Third Quarter Financial Results
6. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
7. Call for Applications: The Amgen Award for Science Teaching Excellence
8. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
9. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
10. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
11. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... BLOOMINGTON, MN (PRWEB) March 25, 2015 ... a breakthrough in nanoparticle technology that will enable ... and many other diseases with a simple breath ... ahead on the U.S. Food and Drug Administration ... 2016 launch of the innovative Nanoparticle Biomarker Tagging ...
(Date:3/25/2015)... /CNW/ - The Gairdner Foundation is pleased to ... recognizing some of the most significant medical discoveries ... the world,s most esteemed medical research prizes, the ... a $100,000 (CDN) prize to each scientist for their work. ... and innovation across the country, inspiring the next ...
(Date:3/25/2015)... 2015 Proove Biosciences , a ... to announce the success of their commercially supported symposium, ... to Optimize the Management of Pain, at the 31st ... Harbor, Maryland on Thursday, March 19th, 2015. ... President Lynn Webster , M.D., former Florida Society ...
(Date:3/25/2015)... 25, 2015 Oxis International, Inc. (OXIS) (OXI.PA) ... commercialization, announced today Oxis CEO Tony Cataldo ... 2015 at 4:15pm EST to update shareholders and other ...     Oxis Chairman and CEO Tony ... been very exciting for Oxis and our shareholders. There ...
Breaking Biology Technology:Ancon Medical Researchers Make Nanotechnology Breakthrough for Disease Screening Technology 2Ancon Medical Researchers Make Nanotechnology Breakthrough for Disease Screening Technology 32015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 22015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 32015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 42015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 52015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 62015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 72015 Canada Gairdner Awards Honour Top Medical Discoveries Around The World 8Proove Biosciences Hosts Symposium on Incorporating Genetic Testing to Optimize the Management of Pain 2Oxis Biotech Inc. Announces Corporate Update Conference Call for March 31 2
... (OTC:,SPOM - News), a leading developer of biosensor and ... that it,has appointed Med Tech and Med Care Associates ... market. , Med Tech and ... healthcare industry and operate with manufacturers,of medical products and ...
... Md., Feb. 17 Human Genome Sciences, Inc. (Nasdaq: ... GSK ) has initiated a Phase 3 ... tolerability of Syncria (R) (albiglutide) in the long-term ... result, HGS will receive a $9 million milestone payment ...
... at the 19th Conference of the Asian Pacific ... Demonstrated Favorable Pharmacokinetics and Significant Reduction in Viral ... privately held biopharmaceutical company, today announced results from ... a controlled release version of nitazoxanide in the ...
Cached Biology Technology:SPO Medical Appoints New US Sales Rep Groups 2SPO Medical Appoints New US Sales Rep Groups 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 4Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C 2Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C 3Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C 4
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
(Date:3/10/2015)... , March 10, 2015   Tute Genomics , ... been selected by next-generation sequencing company PrimBio Research ... exome and targeted gene panel interpretation. PrimBio, ... adopted the most current technologies to support the work ... The company offers two types of exome sequencing services: ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... lacking a special protein found only in germ-line cells ... to a new study from researchers at the University ... of Human Reproduction in Penn's Center for Research in ... investigations point the way to a new type of ...
... In a recent study published in the Journal of ... to play a purely structural and inert role in ... Using antagonists for this molecule, the researchers were able ... drug treatment. , The research appears as the "Paper ...
... of neuroscientists have been indoctrinated into believing that ... by a communication network of brain cells, or ... message called a neurotransmitter. Either neurons release a ... an electrical discharge and enhancing brain activity, or ...
Cached Biology News:Of mice and men's (and women's) contraceptives 2New polysaccharide may help combat multidrug resistance in cancer 2Researchers make surprise discovery that some neurons can transmit three signals at once 2Researchers make surprise discovery that some neurons can transmit three signals at once 3
... designed to rapidly and reliably amplify unknown ... Technology. APAgene provides hassle-free, ready-to use components, ... ingredients are provided in each kit. The ... gap filling, localized cloning of genomic DNA, ...
Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Collected from animals of U.S. origin.Collected from animals of U.S. origin. *Can be used in cell growth studies and immunoassays. *Sterility tested, * Mycoplasma tested upon request, *Endoto...
...
Biology Products: